Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.
Raffaella RoncoGiovanni FrancoMatteo Monzio CompagnoniStefano AlibertiFabrizio LuppiGiovani CorraoPaola FaverioPublished in: ERJ open research (2023)
Direct healthcare costs for patients with asthma are less than half (-52%) and for patients with COPD are 41% higher if compared to those of patients with bronchiectasis. The leading expense items in bronchiectasis are hospitalisations and antibiotics. https://bit.ly/3Iq8AUP.